Abnormal expression of Thy-1 as a novel tumor marker in lung cancer and its prognostic significance

National Medical Journal of China

Volumn 85, Issue 27, 2005, Pages 1921-1925

  Chen, Jin Feng ^a   Zhang, Li Jian ^b   Zhao, Ai Lian ^b   Wang, Yu ^b   Wu, Nan ^b   Xiong, Hong Chao ^b   Liang, Zhen ^b   Li, Ji You ^b   Huang, Xin Fu ^b   Yang, Yue ^b  

^a PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

^b NONE

Author keywords

Carcinoma, non small cell lung; p53; Prognosis; Thy 1 CD90

Indexed keywords

ANTIBODY; PARAFFIN; PROTEIN P53; THY 1 ANTIGEN;

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER STAGING; CANCER SURVIVAL; CELL NUCLEUS; CONTROLLED STUDY; DISEASE MARKER; EMBEDDING; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG PARENCHYMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; TISSUE MICROARRAY;

ADULT; AGED; ANTIGENS, THY-1; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 23044506981     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Mountain CF. Revisions in the international system for staging lung cancer. Chest, 1997, 111: 1710-1717.
2. Mountain CF, Dresler CM. Regional lymph node classification for lung cancer staging. Chest, 1997, 111:1718-1723.
3. Kononen J, Bubendorf L, Kallioniemi A, et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med,1998, 4:844-847.
4. Xiong ZW. The research development of target retrieval method in immunohistochemistry. Chin J Pathol, 1997, 26:124-127.
5. Mason JC, Yarwood H. Tarnok A, et al. Human Thy-1 is cytokine-inducible on vascular endothelial cells and is a signaling molecular regulated by protein kinase C. J Immunol, 1996, 157: 874-883.
6. Saalbach A, Haustein UF, Anderegg U. A ligand of human Thy-1 is localized on polymorphonuclear leukocytes and monocytes and mediates the binding to activated Thy-1 positive microvascular endothelial cells and fibroblasts. J Invest Dermatol, 2000,115:882-888.
7. Saalabch A, Hidebrandt G, Haustein UF, et al. The Thy-1/Thy-1 ligand interaction is involved in binding of melanoma cells to activated Thy-1-positive microvascular endothelial cells. Microvascular Res, 2002,64:86-93.
8. Abeysinghe HR, Cao Q, Xu J, et al. THY1 expression is associated with tumor suppression of human ovarian cancer. Cancer Genet Cytogenet, 2003,143:125-132.
9. Wang DH, Liao SL, Gao ZF, et al. Multivariate analysis of prognostic factors in non-small cell lung cancer, Natl Med J China, 1997, 77:497-500.
10. Wang BC, Li LY, Yao LC, et al. Detection of p53 gene mutations in sputum samples ans their implications in the early diagnosis of lung cancer in suspicious patients. Chin Med J, 2001, 114:694-697.
11. Lee YC, Chang YL, Luh SP, et al. Significance of p53 and Rb protein expression in surgically treated non-small cell lung cancers. Ann Thorac Surg, 1999, 68:343-347.
12. Hommura F, Dosaka-Akita H, Kinoshita I, et al. Predictive value of expression of p16INK4A, retinoblastoma and p53 proteins for the prognosis of non-small cell lung cancers. Br J Cancer, 1999, 81: 696-701.